Select your location
We have detected that you are here: India.
You will be redirected to the website for: India
in: English.
Would you like to see the content for another country or in another language?
HyperQ Stress
Non-invasive diagnosis of ischaemic heart disease
Revolutionising the detection of coronary artery disease
Coronary Artery Disease (CAD) screening is largely based on exercise ECG testing that has a limited diagnostic accuracy, especially in women. Additionally, there are growing concerns over exposure to radiation and cutbacks on payment for costly cardiac imaging.
HyperQ Stress ECG testing provides a low-cost, non-invasive, radiation-free and highly reliable first line CAD diagnostic solution for private cardiology practices as well as cardiology departments in hospitals. HyperQ is based on solid scientific and clinical research.
Features
- Higher sensitivity in diagnosing ischaemia
- Fewer false alarms in non-ischaemic patients
- Performs equally well in women and men
- Provides clear results in patients with equivocal standard exercise ECG test results
Availability in your market is subject to regulatory approval.